Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Floyd Eric
Jan 31 16:30 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jambulingam Thani
Jan 31 16:29 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay
Jan 31 16:29 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Singh Vanila
Jan 31 16:28 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mathias Sheila
Jan 31 16:28 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dubin Michael F
Jan 31 16:28 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sendrow Jerrold
Jan 31 16:28 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bruce Gerald W
Jan 31 16:28 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ruskin Barbara
Jan 31 16:23 ET
Virpax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Jan 2 00:00 ET
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Mathias Sheila
Oct 3, 2023 09:51 ET
Virpax Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Financial Officer Shah Vinay
Aug 16, 2023 17:00 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Shah Vinay
Jun 21, 2023 16:18 ET
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Shah Vinay
Jun 21, 2023 16:17 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bruce Gerald W
Apr 26, 2023 21:00 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ruskin Barbara
Mar 28, 2023 20:05 ET
Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Ruskin Barbara
Mar 28, 2023 20:00 ET
Virpax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anthony P. Mack(26.1%),Virpax Pharmaceuticals, LLC(23.3%)
Feb 14, 2023 16:05 ET
Virpax Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Mack Anthony P.
Feb 7, 2023 21:30 ET
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Jan 27, 2023 20:30 ET
No Data
No Data